Carbidopa And Levodopa Tablet
Product Images NDC 0093-9701

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 0093-9701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

67944b5f-figure-01 (Image 1)

FDA Label Image

67944b5f-figure-02 (Image 2)

FDA Label Image

Cl 10 mg/100 mg -100s (Image 3)

This is a description of Levodopa Tablets, USP with a strength of 10 mg/100 mg. The tablets contain Levodopa and Carbidopa. The product is manufactured by Teva Pharmaceuticals and packaged in a bottle with 100 tablets. The dosage information can be found on the package. It also includes a GTIN code for the product. The medication should be dispensed in a tight container as defined by USP standards. The text also provides information about the manufacturer's location and distribution for the product. The code area is provided for serialization purposes.*

FDA Label Image

Label (Image 4)

Teva Levodopa and Carbidopa Tablets, USP 25mg/100mg is a medication prescribed for the treatment of Parkinson's disease. It is available in a bottle of 100 tablets with a unique serialization coding area. To maintain potency, it should be stored in a tight, light-resistant container at a temperature between 25°C and 30°C. The manufacturer is Teva Czech Industries located in Opava, Czech Republic. The product is manufactured for Teva Pharmaceuticals USA, Inc. located in Parsippany, NJ.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.